| Primary |
| Atrial Fibrillation |
22.1% |
| Drug Use For Unknown Indication |
19.7% |
| Ventricular Tachycardia |
13.0% |
| Product Used For Unknown Indication |
7.9% |
| Arrhythmia |
7.0% |
| Hypertension |
6.0% |
| Overdose |
3.8% |
| Supraventricular Tachycardia |
3.4% |
| Atrial Flutter |
2.4% |
| Diabetes Mellitus |
2.4% |
| Essential Hypertension |
1.7% |
| Ventricular Arrhythmia |
1.7% |
| Neoplasm |
1.4% |
| Tachycardia Foetal |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Ventricular Fibrillation |
1.2% |
| Completed Suicide |
1.0% |
| Influenza |
1.0% |
| Palpitations |
1.0% |
| Pneumonia |
1.0% |
|
| Torsade De Pointes |
13.8% |
| Ventricular Tachycardia |
11.4% |
| Ventricular Fibrillation |
7.3% |
| Renal Failure |
6.5% |
| Syncope |
6.5% |
| Dizziness |
5.7% |
| Electrocardiogram Qt Prolonged |
5.7% |
| Fatigue |
4.9% |
| Pneumonia |
4.9% |
| Drug Ineffective |
3.3% |
| Product Quality Issue |
3.3% |
| Renal Failure Acute |
3.3% |
| Tachycardia |
3.3% |
| Toxicity To Various Agents |
3.3% |
| Vision Blurred |
3.3% |
| Visual Acuity Reduced |
3.3% |
| Vomiting |
3.3% |
| Acute Hepatic Failure |
2.4% |
| Atrial Fibrillation |
2.4% |
| Bradycardia |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
20.6% |
| Drug Use For Unknown Indication |
17.1% |
| Atrial Fibrillation |
15.7% |
| Hypertension |
9.6% |
| Ventricular Tachycardia |
5.0% |
| Multiple Drug Overdose |
4.6% |
| Arrhythmia |
3.6% |
| Atrial Flutter |
3.4% |
| Overdose |
3.4% |
| Rheumatoid Arthritis |
3.0% |
| Dementia Alzheimer's Type |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Tachycardia Foetal |
1.6% |
| Depression |
1.4% |
| Prophylaxis |
1.4% |
| Essential Hypertension |
1.3% |
| Lung Neoplasm |
1.1% |
| Parkinson's Disease |
1.1% |
| Diabetes Mellitus |
1.0% |
| Ill-defined Disorder |
1.0% |
|
| Ventricular Tachycardia |
11.3% |
| Renal Failure |
10.4% |
| Torsade De Pointes |
10.4% |
| Drug Ineffective |
6.1% |
| Dizziness |
5.2% |
| Syncope |
5.2% |
| Ventricular Arrhythmia |
5.2% |
| Death |
4.3% |
| Electrocardiogram Qt Prolonged |
4.3% |
| Fatigue |
4.3% |
| Oedema Peripheral |
4.3% |
| Atrial Fibrillation |
3.5% |
| Bradycardia |
3.5% |
| Malaise |
3.5% |
| Nausea |
3.5% |
| Renal Failure Chronic |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Alopecia |
2.6% |
| Bladder Disorder |
2.6% |
| Colitis Ischaemic |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.1% |
| Drug Use For Unknown Indication |
16.2% |
| Atrial Fibrillation |
13.4% |
| Hypertension |
12.2% |
| Prophylaxis |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Cardiac Disorder |
3.0% |
| Blood Cholesterol Increased |
2.6% |
| Pain |
2.6% |
| Multiple Myeloma |
2.3% |
| Diabetes Mellitus |
2.3% |
| Osteoporosis |
2.2% |
| Arrhythmia |
2.1% |
| Hypothyroidism |
2.0% |
| Type 2 Diabetes Mellitus |
1.9% |
| Depression |
1.9% |
| Blood Pressure |
1.4% |
| Insomnia |
1.2% |
| Hypercholesterolaemia |
1.1% |
| Atrial Flutter |
1.1% |
|
| Vomiting |
9.3% |
| Weight Decreased |
9.1% |
| Atrial Fibrillation |
6.8% |
| Dizziness |
6.1% |
| Dyspnoea |
5.9% |
| Death |
5.4% |
| International Normalised Ratio Increased |
5.0% |
| Flushing |
4.8% |
| Headache |
4.8% |
| Nausea |
4.5% |
| Renal Failure Acute |
4.5% |
| Cerebrovascular Accident |
4.3% |
| Pyrexia |
4.3% |
| Transient Ischaemic Attack |
3.9% |
| Urinary Tract Infection |
3.9% |
| Dyspepsia |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Diarrhoea |
3.4% |
| Fatigue |
3.4% |
| Hyponatraemia |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
41.0% |
| Drug Use For Unknown Indication |
21.9% |
| Atrial Fibrillation |
3.8% |
| Barrett's Oesophagus |
2.9% |
| H1n1 Influenza |
2.9% |
| Hiv Infection |
2.9% |
| Hypertension |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Acquired Immunodeficiency Syndrome |
1.9% |
| Cardiac Failure |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Diabetes Mellitus |
1.9% |
| Dyslipidaemia |
1.9% |
| Dyspepsia |
1.9% |
| Neuralgia |
1.9% |
| Prophylaxis |
1.9% |
| Agitation |
1.0% |
| Arrhythmia |
1.0% |
| Arrhythmia Prophylaxis |
1.0% |
| Asthma |
1.0% |
|
| Drug Interaction |
13.3% |
| Orthostatic Hypotension |
10.0% |
| Torsade De Pointes |
10.0% |
| Electrocardiogram Qt Prolonged |
6.7% |
| Hypersomnia |
6.7% |
| Malaise |
6.7% |
| Pharyngitis |
6.7% |
| Gastrointestinal Haemorrhage |
3.3% |
| Haematoma |
3.3% |
| Heart Rate Increased |
3.3% |
| Hypoglycaemia |
3.3% |
| Incorrect Drug Administration Duration |
3.3% |
| International Normalised Ratio Fluctuation |
3.3% |
| Paraesthesia |
3.3% |
| Renal Failure |
3.3% |
| Renal Failure Acute |
3.3% |
| Syncope |
3.3% |
| Viral Infection |
3.3% |
| White Blood Cell Count Increased |
3.3% |
|
